BusinessInterpace Diagnostics Enters Agreement with One of the Largest, Integrated Health Systems in the USBy Nasdaq OMXApr 18, 2018, 12:30 PM UTC
BusinessHitachi High-Tech Participates in OmniSeq Series B and Secures Japanese Distribution RightsBy Nasdaq OMXApr 12, 2018, 1:00 PM UTC
BusinessPositiveID Corporation Announces Lawrence Livermore National Laboratory Evaluation of PositiveID’s FireflyDXBy Nasdaq OMXJan 22, 2018, 1:01 PM UTC
BusinessPositiveID’s ExcitePCR Subsidiary to Present and Exhibit at the Seed Central Tech Showcase on January 11thBy Nasdaq OMXJan 3, 2018, 1:02 PM UTC
BusinessPositiveID’s ExcitePCR Named Major Player in Molecular Diagnostics Industry ReportBy Nasdaq OMXDec 14, 2017, 1:01 PM UTC
BusinessClinical Utility Study Indicates Potential for TruGraf™ Test to Replace Surveillance Biopsies in Kidney Transplant Recipients with Stable Renal FunctionBy Nasdaq OMXNov 28, 2017, 4:51 PM UTC
BusinessMolecular Diagnostics Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2012–2022By Nasdaq OMXNov 22, 2017, 10:23 AM UTC
BusinessStudy Shows TruGraf Blood Test Enables Non-invasive Detection of Immune Quiescent Kidney Transplant RecipientsBy Nasdaq OMXOct 24, 2017, 1:25 PM UTC
